Cellectar Biosciences Inc — Cash Flow (NASDAQ:CLRB) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -13.93 M-22.57 M-25.22 M-32.38 M-47.58 M-23.12 M -23.12 M Cash from investing activities -62.35 K-141.36 K-225.97 K-864.04 K-104.19 K-5 880 — Cash from financing activities 60.55 M1.25 M9.61 M22.94 M61.41 M13.03 M — Free cash flow -14 M-22.71 M-25.45 M-33.24 M-47.69 M-23.12 M -23.12 M

Haberler

Cellectar kanser çalışmasına ilk hastayı kaydetti

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Abivax (NASDAQ:ABVX), Rich Sparkle Holdings (NASDAQ:ANPA)

Cellectar secures multi-year supply of alpha-emitting radioisotopes

Cellectar Biosciences hisseleri FDA’nın nadir pediatrik hastalık statüsü vermesiyle yükseldi

FDA, Cellectar’ın kanser tedavisine nadir pediatrik ilaç statüsü verdi

Cellectar Biosciences stock soars after FDA grants rare pediatric designation

FDA grants rare pediatric drug designation to Cellectar’s cancer therapy

Cellectar’s experimental cancer drug shows promise in pancreatic models

Cellectar Biosciences, hisse senedi garantisi kullanımı ve yeni teşvik garantileriyle 5,8 milyon dolar topladı

Cellectar Biosciences raises $5.8 million through warrant exercise and new inducement warrants

Cellectar Biosciences, hisse senedi varantlarının kullanımıyla 5,8 milyon dolar topladı

Cellectar Biosciences raises $5.8 million through warrant exercise